Yan Leyfman: Episode 3 of The Translational Edge on Cancer Anticoagulation Is Now Live on Shuf
Yan Leyfman, Medical Oncologist, Co-Founder and Executive Director of MedNews Week, Medical Correspondent at OncLive, shared Jeremy Bellaiche‘s post on LinkedIn, adding:
“Episode 3 of The Translational Edge is now live on Shuf.
As oncology care becomes more personalized, one critical question remains:
Are we dosing based on evidence—or outdated assumptions?
This episode explores the evolving science of anticoagulation in cancer patients with obesity—and how aligning practice with data can directly impact outcomes.
Translating breakthroughs into impact.
Jeremy Bellaiche, Founder of Shuf, shared a post on LinkedIn:
“Excited to share the episode 3 of The Translational Edge season 2 with Yan Leyfman exclusively on Shuf !
Treating Blood Clots in Cancer Patients with Obesity: Why Dosing Finally Caught Up with Reality.”
Stay updated with Hemostasis Today.
-
Aug 14, 2026, 11:40Liz Devlin: When HHT Affects More Than What We Can See
-
Aug 14, 2026, 11:29Archil Jaliashvili: Can Italy Reduce Its Dependence on Imported Plasma
-
Aug 14, 2026, 11:21Osama Alabdi: Never Ignore a Weak Reaction in the Blood Bank
-
Aug 14, 2026, 11:14Yohan Santin: How Lysosomal Dysfunction Drives Cardiac Aging
-
Aug 14, 2026, 11:06Nicolas Schommer: When Neutrophils Turn Metabolic Stress Into Organ Injury
-
Aug 14, 2026, 10:49Pablo Corral: Can One Infusion Lower LDL for Years
-
Aug 14, 2026, 08:17Maha Othman: Celebrating Research and Collaboration at the Sinclair Cancer Research Institute 2026 Annual Retreat
-
Aug 14, 2026, 06:26Delivering Gene Therapy in Hemophilia – ISTH
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children